As of April 23, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases in the United States year-to-date, with 92% among unvaccinated individuals or those of unknown status, concentrated in outbreaks in South Carolina (over 1,000 cases, recently declared over), Texas, Utah, and Arizona. This surge reflects declining vaccination coverage in under-immunized communities—below the 95% herd immunity threshold for the highly contagious paramyxovirus (R0 of 12–18)—fueled by imported cases from global hotspots. Growth has slowed recently, with just 44 new cases last week, but Utah's ongoing transmission poses risks amid summer travel. Traders should track CDC weekly surveillance updates and state reports through December 31, as school reopenings and epidemiological shifts could drive final counts.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Casos de sarampión en EE. UU. en 2026?
¿Casos de sarampión en EE. UU. en 2026?
$7,648,701 Vol.
$7,648,701 Vol.
31 dic 2026
↑2k
99%
↑3k
69%
↑4k
35%
↑5k
14%
↑7,5k
13%
↑10k
10%
↑12.5k
8%
$7,648,701 Vol.
$7,648,701 Vol.
31 dic 2026
↑2k
$42,441 Vol.
99%
↑3k
$47,758 Vol.
69%
↑4k
$167,668 Vol.
35%
↑5k
$213,832 Vol.
14%
↑7,5k
$170,789 Vol.
13%
↑10k
$6,487,556 Vol.
10%
↑12.5k
$343,897 Vol.
8%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 23, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases in the United States year-to-date, with 92% among unvaccinated individuals or those of unknown status, concentrated in outbreaks in South Carolina (over 1,000 cases, recently declared over), Texas, Utah, and Arizona. This surge reflects declining vaccination coverage in under-immunized communities—below the 95% herd immunity threshold for the highly contagious paramyxovirus (R0 of 12–18)—fueled by imported cases from global hotspots. Growth has slowed recently, with just 44 new cases last week, but Utah's ongoing transmission poses risks amid summer travel. Traders should track CDC weekly surveillance updates and state reports through December 31, as school reopenings and epidemiological shifts could drive final counts.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Dec 1, 2025, 12:56 PM ET
Volumen
$7,648,701Fecha de finalización
31 dic 2026Mercado abierto
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 23, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases in the United States year-to-date, with 92% among unvaccinated individuals or those of unknown status, concentrated in outbreaks in South Carolina (over 1,000 cases, recently declared over), Texas, Utah, and Arizona. This surge reflects declining vaccination coverage in under-immunized communities—below the 95% herd immunity threshold for the highly contagious paramyxovirus (R0 of 12–18)—fueled by imported cases from global hotspots. Growth has slowed recently, with just 44 new cases last week, but Utah's ongoing transmission poses risks amid summer travel. Traders should track CDC weekly surveillance updates and state reports through December 31, as school reopenings and epidemiological shifts could drive final counts.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$7,648,701Fecha de finalización
31 dic 2026Mercado abierto
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...As of April 23, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases in the United States year-to-date, with 92% among unvaccinated individuals or those of unknown status, concentrated in outbreaks in South Carolina (over 1,000 cases, recently declared over), Texas, Utah, and Arizona. This surge reflects declining vaccination coverage in under-immunized communities—below the 95% herd immunity threshold for the highly contagious paramyxovirus (R0 of 12–18)—fueled by imported cases from global hotspots. Growth has slowed recently, with just 44 new cases last week, but Utah's ongoing transmission poses risks amid summer travel. Traders should track CDC weekly surveillance updates and state reports through December 31, as school reopenings and epidemiological shifts could drive final counts.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes